Transplantation of conjunctival limbal autograft and amniotic membrane vs mitomycin C and amniotic membrane in treatment of recurrent pterygium

被引:24
作者
Fallah, M. R. [1 ]
Golabdar, M. R. [1 ]
Amozadeh, J. [1 ]
Zare, M. A. [1 ]
Moghimi, S. [1 ]
Fakhraee, G. [1 ]
机构
[1] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Dept Ophthalmol, Tehran, Iran
关键词
conjunctival limbal autograft; amniotic membrane transplantation; mitomycin C; recurrent pterygium;
D O I
10.1038/sj.eye.6702657
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: To compare the efficacy and complications of conjunctival limbal autograft (CLAU) and amniotic membrane transplantation (AMT) vs intraoperative mitomycin C (MMC) and AMT for treatment of recurrent pterygium. Methods: Forty eyes of 40 patients with recurrent pterygium underwent CLAU and AMT (20 eyes) or intraoperative MMC (0.02%, 3 min) and AMT (20 eyes). Three eyes (15%) had symblepharon before surgery in each group. Recurrence was compared in each group by using chi(2) test. Results: No major postoperative complications occurred during 6-19 months of follow-up. In CLAU/AMT group, no pterygium recurrence was observed. Recurrence occurred in four eyes (20%) in MMC/AMT group after 3 and 4 months (P-value = 0.035, chi(2) test). No recurrence of pterygium or symblepharon was seen in six eyes with recurrent pterygium and symblepharon (three eyes in each group). Conclusion: CLAU with AMT seems to be more effective than intraoperative MMC with AMT for treatment of recurrent pterygium.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 27 条
[21]  
Tekin NF, 2001, OPHTHALMIC SURG LAS, V32, P464
[22]  
Ti Seng-Ei, 2002, Curr Opin Ophthalmol, V13, P204, DOI 10.1097/00055735-200208000-00003
[23]  
Wong A K, 2000, Indian J Ophthalmol, V48, P21
[24]  
Xi Xing-hua, 2003, Hunan Yike Daxue Xuebao, V28, P149
[25]   Intraoperative mitomycin C in the treatment of pterygium [J].
Yanyali, AC ;
Talu, H ;
Alp, BN ;
Karabas, L ;
Manav, G ;
Caglar, Y .
CORNEA, 2000, 19 (04) :471-473
[26]   Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction [J].
Yao, YF ;
Qiu, WY ;
Zhang, YM ;
Tseng, SCG .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 244 (02) :232-236
[27]   A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium [J].
Young, AL ;
Leung, GYS ;
Wong, AKK ;
Cheng, LL ;
Lam, DSC .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (08) :995-997